Roche Holding AG (RHHBY) Stock: Revenue, Earnings, Margins & Valuation
Roche Holding AG (RHHBY), Switzerland at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in CHF. Free and without signup.
Roche Holding AG key figures (FY 2025)
| Revenue | 63.36 CHF bn |
|---|---|
| Net income | 13.80 CHF bn |
| Net margin | 21.8 % |
Roche Holding AG revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | 47.67 CHF bn | 77.5 % |
| Diagnostics | 13.85 CHF bn | 22.5 % |
Roche Holding AG earnings analysis
In the latest reported fiscal year (FY 2025), Roche Holding AG generated revenue of 63.36 CHF bn. The largest segment is Pharmaceuticals with 47.67 CHF bn, about 77.5 % of total segment revenue.
Roche Holding AG business model
The income statement of Roche Holding AG is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Roche Holding AG
- Novartis AG stock (NVS)
- Qualcomm Incorporated stock (QCOM)
- Royal Bank of Canada stock (RY.TO)
- Procter & Gamble Co. stock (PG)
- RTX Corporation stock (RTX)
- Philip Morris International stock (PM)
- S&P Global Inc. stock (SPGI)
- PepsiCo Inc. stock (PEP)
- Salesforce Inc. stock (CRM)
- Palantir Technologies stock (PLTR)